Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 2 4Phase NA 2Phase 3 2Phase EARLY_PHASE1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Lymphoma, Follicular 1Inflammation 1Chronic Pain 1Breast Neoplasms 1Acute Pain 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 361Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Anti-Inflammatory Agents, Non-Steroidal × Clear all
NCT01789216 2021-02-03

PAIN

Major Extremity Trauma Research Consortium

Phase 3 Completed
450 enrolled
Lymphoid

Lymphoma, Follicular, Chronic Pain, Acute Pain

NCT02141139 2014-05-19

Perioperative Inflammation and Breast Cancer Outcome

Samsung Medical Center

Phase 3 Unknown
1,568 enrolled
Breast

Breast Neoplasms, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡